A sterile non-bioabsorbable tubular device intended to be implanted in an obstructed ureter (e.g., from stone, stricture, compression, fibrosis, trauma) to maintain luminal patency allowing urine to drain from the renal pelvis to the bladder. It is made of a s
| Company | Devices | Share |
|---|---|---|
| Boston Scientific Corporation | 962 | 34% |
| Cook Incorporated | 571 | 20% |
| Coloplast A/S | 456 | 16% |
| C. R. Bard, Inc. | 214 | 8% |
| Gyrus Acmi, Llc | 194 | 7% |
| Zhejiang Chuangxiang Medical Technology Co., Ltd. | 174 | 6% |
| Promepla | 60 | 2% |
| Q Urological Corporation | 54 | 2% |
| Allwin Medical Devices, Inc. | 39 | 1% |
| Merit Medical Systems, Inc. | 37 | 1% |
| Applied Medical Resources Corporation | 37 | 1% |
| Dornier Medtech America, Inc. | 25 | 1% |
Company = labeler of record on GUDID. 13 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| FAD | STENT, URETERAL | 2,735 |
| FAD | Stent, Ureteral | 618 |
| FAD | Stent, ureteral | 149 |
| FGE | CATHETER, BILIARY, DIAGNOSTIC | 135 |
| LJE | CATHETER, NEPHROSTOMY | 42 |
| FFA | TUBE, DRAINAGE, SUPRAPUBIC | 11 |
Use these as the dimensions to specify in a tender line.
2,826 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Polymeric ureteral stent", from 13 companies. The largest labeler is Boston Scientific Corporation with 34% of records.
FAD (STENT, URETERAL), FAD (Stent, Ureteral), FAD (Stent, ureteral), FGE (CATHETER, BILIARY, DIAGNOSTIC)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add polymeric ureteral stent to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.